Company profilePharmaceutical#1110 of 1,318 in Pakistan✓ No DRAP alerts

MAZTON PHAMRCEUTICALS

Pharmaceutical company · 2 brands · 2 molecules

Ranked #34 of 58 companies in Skin Conditions

2 registered products 2 pharmaceutical brands 2 distinct molecules 0 DRAP alerts

Company overview

2
registered products
2
pharmaceutical brands
2
distinct molecules
2
therapeutic classes
0
DRAP alerts

MAZTON PHAMRCEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 2 product registrations across 2 distinct molecules. Its portfolio is concentrated in Skin Conditions and Anti-Acne Preparations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MAZTON

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Skin Conditions · 2Anti-Acne Preparations · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 1Acne/Topical · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 290 – Rs 290
Servaid2 products · Rs 165 – Rs 283.02
Median across source: Rs 290

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.2 shared molecules
GSK Pakistan Limited2 shared molecules
VALOR PHARMACEUTICALS2 shared molecules
Albro Pharmaceuticals2 shared molecules
PANACEA PHARMACEUTICALS2 shared molecules
CARAWAY PHARMACEUTICALS2 shared molecules
PEARL PHARMACEUTICALS2 shared molecules

Get the full profile for MAZTON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.